-
1
TRYBE®: an Fc-free antibody format with three monovalent targeting arms engineered for long in vivo half-life
Published 2023-12-01Subjects: Get full text
Article -
2
“Stapling” scFv for multispecific biotherapeutics of superior properties
Published 2023-12-01Subjects: “…Multi-specific antibody…”
Get full text
Article -
3
Innovative strategies for T cell engagers for cancer immunotherapy
Published 2025-12-01Subjects: Get full text
Article